Gonclear Tablet is a combination pharmaceutical formulation containing Acebrophylline 100 mg and Acetylcysteine 600 mg, indicated for the management of respiratory conditions characterized by bronchial obstruction and excessive mucus production. Acebrophylline, a xanthine derivative with bronchodilator and mucosecretolytic properties, facilitates airway relaxation and enhances mucociliary clearance, thereby improving airflow in obstructive pulmonary diseases such as chronic bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Acetylcysteine acts as a mucolytic agent by breaking disulfide bonds in the mucus glycoproteins, reducing mucus viscosity and promoting expectoration. The synergistic action of these two active ingredients aids in relieving symptoms such as cough, wheezing, and breathlessness, while also preventing mucus retention and secondary infections. Gonclear Tablet is typically administered orally, with dosage and duration tailored according to clinical severity and patient response. It is advisable to use this medication under medical supervision, especially in patients with hepatic or renal impairment. Common side effects may include gastrointestinal discomfort and hypersensitivity reactions. Gonclear Tablet should be used cautiously in individuals with peptic ulcer disease or arrhythmias. Overall, Gonclear Tablet offers an effective therapeutic option for improving respiratory function and enhancing quality of life in patients with obstructive airway diseases.